Tue, September 17, 2024

Leland Gershell Maintained (CAPR) at Buy with Increased Target to $15 on, Sep 17th, 2024

Leland Gershell of Oppenheimer, Maintained "Capricor Therapeutics, Inc." (CAPR) at Buy with Increased Target from $14 to $15 on, Sep 17th, 2024.

Leland, nor any peers, have made any analyst calls on CAPR in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30